TG Therapeutics Inc
(FRA:NKB2)
€
51
+0.80 (+1.59%)
Market Cap: 7.68 Bil
Enterprise Value: 7.89 Bil
PE Ratio: 19.97
PB Ratio: 15.00
GF Score: 81/100 TG Therapeutics Inc (FRA:NKB2) Transcripts
- 1